Endovia Health Sciences (EDVA) Cash from Investing Activities Growth (3y) (2018 - 2023)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Cash from Investing Activities Growth (3y) (2018 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.06 Bn | 133.21 Bn | 2.84 Bn | 46.78% |
| 2 | Regeneron Pharmaceuticals | 86.96 Bn | 78.97 Bn | 3.93 Bn | 66.14% |
| 3 | Argenx Se | 64.93 Bn | 59.74 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.22 Bn | 52.08 Bn | 52.00 Mn | -44.69% |
| 5 | Revolution Medicines | 44.59 Bn | 44.59 Bn | - | - |
| 6 | BeOne Medicines | 40.43 Bn | 35.33 Bn | 1.53 Bn | -39.73% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | -246.81% |
| 8 | Royalty Pharma | 28.17 Bn | 27.34 Bn | - | -53.57% |
| 9 | Insmed | 27.60 Bn | 26.43 Bn | 358.27 Mn | 27.84% |
| 10 | Endovia Health Sciences | 821,701.01 | 578,999.01 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 86.49% |
| Jun 30, 2023 | 69.83% |
| Mar 31, 2023 | 49.06% |
| Dec 31, 2022 | -179.97% |
| Sep 30, 2022 | -103.17% |
| Dec 31, 2020 | -420.47% |
| Sep 30, 2020 | 4.06% |
| Jun 30, 2020 | -58.60% |
| Mar 31, 2020 | -82.27% |
| Dec 31, 2019 | 42.65% |
| Sep 30, 2019 | 26.81% |
| Jun 30, 2019 | 32.74% |
| Mar 31, 2019 | 28.78% |
| Dec 31, 2018 | -41.42% |
| Sep 30, 2018 | -58.43% |
| Jun 30, 2018 | -52.23% |
| Mar 31, 2018 | -54.18% |